Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Operating Margin (2016 - 2025)

Historic Operating Margin for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to 24.29%.

  • Cryo Cell International's Operating Margin rose 70600.0% to 24.29% in Q3 2025 from the same period last year, while for Aug 2025 it was 13.63%, marking a year-over-year increase of 531200.0%. This contributed to the annual value of 10.88% for FY2024, which is 501400.0% up from last year.
  • Latest data reveals that Cryo Cell International reported Operating Margin of 24.29% as of Q3 2025, which was up 70600.0% from 18.83% recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Operating Margin peaked at 27.69% during Q2 2021, and registered a low of 205.37% during Q4 2023.
  • Over the past 5 years, Cryo Cell International's median Operating Margin value was 15.65% (recorded in 2022), while the average stood at 2.81%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -2105900bps in 2023, then surged by 2038400bps in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's Operating Margin stood at 11.05% in 2021, then surged by 147bps to 5.22% in 2022, then plummeted by -4033bps to 205.37% in 2023, then skyrocketed by 99bps to 1.52% in 2024, then soared by 1693bps to 24.29% in 2025.
  • Its Operating Margin was 24.29% in Q3 2025, compared to 18.83% in Q2 2025 and 13.25% in Q1 2025.